Skip to content

Evaluation of the Impact of DiGA´s in Patients with Type II Diabetes mellitus in daily practice

Evaluation of the Impact of DiGA´s in Patients with Type II Diabetes mellitus in daily practice - EDDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00027392
Enrollment
50
Registered
2021-12-07
Start date
2021-05-21
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E11

Interventions

Group 1: Intervention group: Data collection 3 months prospectively with the DiGA Vitadio added to DMP standard diabetes care Group 2: Intraindividual control group: Data collection of the same patien

Sponsors

Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden Medizinische Klinik III Abteilung Prävention und Versorgung des Diabetes
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Patients = 18 years old • Type 2 diabetes patients benefitting from improved self-management • Patients using/willing to use a Diabetes DiGA as part of their diabetes management • HbA1c at baseline = 6.5 % and = 11.0 % • Patients with internet access and a computer and/or smartphone compatible with the Vitadio DiGA • Digital literacy to use a smartphone adequately and willing to use it for their diabetes self-management • Sufficient understanding of user interface (UI) of the Vitadio DiGA • Participants willing and able to comply with all scheduled visits, laboratory tests, lifestyle considerations and other study procedures • Participants capable of giving personal informed consent

Exclusion criteria

Exclusion criteria: • Patients using other Apps for their diabetes management • Patients who have been using a Diabetes DiGA in the past twelve months •Patients with impairments – including mental or psychic impairments – or conditions which, in the opinion of the investigator, would seriously compromise the integrity of the study • Patients under 18 years of age • Patients participating in a weight loss program in the last 6 months • Patients treated with an insulin pump or continuous glucose management (CGM)

Design outcomes

Primary

MeasureTime frame
Change in HbA1c during the use of Vitadio (digital health application)

Secondary

MeasureTime frame
changes in quality of life, depression and patient self-management with the using the Diabetes DiGA measured by the daily conducted blood glucose values and questionnaire SDSCA, PHQ-9, SF-12. • Patient self-management (SDSCA Questionnaire) • Depression (PHQ-9 Questionnaire) • Quality of life (SF-12 Questionnaires) Body fat change measured as: • Bodyweight change (reported by patients via questionnaire) • Waist circumference change (reported by patients via questionnaire)

Countries

Germany

Contacts

Public ContactPeter Schwarz

Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden Medizinische Klinik III Abteilung Prävention und Versorgung des Diabetes

peter.schwarz@uniklikum-dresden.de+49 351 458 2715

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026